Skip to main content
logo
Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
89.14
-1.17 (-1.30%)
Mar 20, 2026, 1:58 PM EDT - Market open

Rhythm Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
6,0877,1943,4932,7321,649502
Market Cap Growth
81.75%105.97%27.85%65.71%228.51%-61.84%
Enterprise Value
5,8546,9393,3192,4561,317208.92
Last Close Price
89.14107.0455.9845.9729.129.98
PE Ratio
--34.42-12.90-14.37-8.39-7.13
PS Ratio
32.3137.9126.8435.2869.74159.11
PB Ratio
43.6451.73160.7416.096.241.77
P/TBV Ratio
41.6550.02157.1415.625.741.74
P/FCF Ratio
--61.68-30.67-20.06-9.49-3.43
P/OCF Ratio
--62.19-30.67-20.06-9.51-3.44
EV/Sales Ratio
30.8536.5725.5031.7355.7066.24
EV/EBITDA Ratio
--36.39-12.57-13.45-7.42-1.24
EV/EBIT Ratio
--36.14-12.50-13.32-7.35-1.23
EV/FCF Ratio
--59.50-29.14-18.04-7.58-1.43
Debt / Equity Ratio
0.010.010.020.000.000.01
Debt / EBITDA Ratio
-0.02-0.02-0.01-0.01-0.01-0.01
Debt / FCF Ratio
-0.03-0.03-0.04-0.01-0.01-0.02
Net Debt / Equity Ratio
-2.77-2.77-14.57-1.62-1.25-1.03
Net Debt / EBITDA Ratio
2.022.021.201.501.871.73
Net Debt / FCF Ratio
3.303.302.782.021.912.00
Asset Turnover
0.430.430.360.220.070.01
Inventory Turnover
0.880.880.981.611.4110.79
Quick Ratio
3.923.922.945.278.536.81
Current Ratio
4.414.413.245.588.907.10
Return on Equity (ROE)
-90.45%-90.45%-155.91%-85.10%-66.05%-30.89%
Return on Assets (ROA)
-44.13%-44.13%-73.34%-51.71%-50.32%-65.84%
Return on Invested Capital (ROIC)
3915.44%3915.44%-112175.52%-2424.57%-3462.31%7853.11%
Return on Capital Employed (ROCE)
-58.99%-58.99%-95.80%-59.45%-56.99%-74.72%
Earnings Yield
-3.29%-2.91%-7.75%-6.96%-11.92%-14.03%
FCF Yield
-1.90%-1.62%-3.26%-4.99%-10.54%-29.18%
Buyback Yield / Dilution
-4.02%-3.31%-1.61%-2.10%-8.58%-33.17%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q